Abstract
It is unclear whether hypertension and antihypertensive medication use are associated with breast cancer. In order to examine these associations, we conducted a case–control study among women aged 50–75 years. Breast cancer cases were ascertained via a population-based cancer registry (n=523) and controls were ascertained via random-digit-dialing (n=131). Participants completed a self-administered questionnaire which queried history of hypertension, antihypertensive medication use and risk factors. Unconditional logistic regression was used to estimate the odds ratio (OR) and 95% confidence intervals (CI), adjusted for age, body mass index (BMI), diabetes, smoking, alcohol use, menopausal status, family history of breast or ovarian cancer, age at first full-term pregnancy and education. History of treated hypertension was associated with significant increased risk of breast cancer (OR, 1.77; 95% CI, 1.04–3.03) and this association appeared only in women with BMI ⩾25 kg/m2 (OR, 2.30; 95% CI, 1.12–4.71). Diuretic use was also associated with elevated breast cancer risk (OR, 1.79; 95% CI, 1.07–3.01). The risk associated with diuretic use increased with duration of use (P for trend, <0.01). Use of other blood pressure medications was not found to be associated with breast cancer risk. These results support a positive association between treated hypertension, diuretic use and breast cancer risk among women aged 50–75 years.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Ries LAG, Eisner MP, Kosary CL, Hankey BF, Miller BA, Clegg L et al. (eds). SEER Cancer Statistics Review, 1975–2002. National Cancer Institute: Bethesda, MD, 2005 (http://seer.cancer.gov/csr/1975_2002/based on November 2004 SEER data submission, posted to the SEER web site 2005).
National Center for Health Statistics. Health, United States, 2004 with Chartbook on Trends in the Health of Americans. National Center for Health Statistics: Hyattsville, MD, 2004.
Friedenreich CM . Review of anthropometric factors and breast cancer risk. Eur J Cancer Prev 2001; 10: 15–32.
Manjer J, Kaaks R, Riboli E, Berglund G . Risk of breast cancer in relation to anthropometry, blood pressure, blood lipids and glucose metabolism: a prospective study within the Malmo Preventive Project. Eur J Cancer Prev 2001; 10: 33–42.
Jee SH, Kim HJ, Lee J . Obesity, insulin resistance and cancer risk. Yonsei Med J 2005; 46: 449–455.
Peeters PH, van Noord PA, Hoes AW, Grobbee DE . Hypertension, antihypertensive drugs, and mortality from cancer among women. J Hypertens 1998; 16: 941–947.
Chow W-H, Gridley G, Fraumeni JF, Bengt J . Obesity, hypertension, and the risk of kidney cancer in men. N Engl J Med 2000; 343: 1305–1311.
Grossman E, Messerli FH, Boyko V, Goldbourt U . Is there an association between hypertension and cancer mortality? Am J Med 2002; 112: 479–486.
Soler M, Chatenoud L, Negri E, Parazzini F, Franceschi S, La Vecchia C . Hypertension and hormone-related neoplasms in women. Hypertension 1999; 34: 320–325.
Weiderpass E, Persson I, Adami H-O, Magnusson C, Lindgren A, Baron JA . Body size in different periods of life, diabetes mellitus, hypertension, and risk of postmenopausal endometrial cancer (Sweden). Cancer Causes Control 2000; 11: 185–192.
Furberg A-S, Thune I . Metabolic abnormalities (hypertension, hyperglycemia and overweight), lifestyle (high energy intake and physical inactivity) and endometrial cancer risk in a Norwegian cohort. Int J Cancer 2003; 104: 669–676.
Tornberg SA, Holm LE, Carstensen JM . Breast cancer risk in relation to serum cholesterol, serum beta-lipoprotein, height, weight, and blood pressure. Acta Oncol 1988; 27: 31–37.
Peeters PH, van Noord PA, Hoes AW, Fracheboud J, Gimbrere CH, Grobbee DE . Hypertension and breast cancer risk in a 19-year follow-up study (the DOM cohort). J Hypertens 2000; 18: 249–254.
Lindgren AM, Nissinen AM, Tuomilehto JO, Pukkala E . Cancer pattern among hypertensive patients in North Karelia, Finland. J Hum Hypertens 2005; 19: 373–379.
Anton-Culver H, Culver BD, Kurosaki T, Osann KE, Lee JB . Incidence of lung cancer by histological type from a population-based registry. Cancer Res 1988; 48: 6580–6583.
Seiffert JE, Price WT, Gordon B . The California Tumor Registry: a state-of-the-art model for a regionalized, automated, population-based registry. Top Health Rec Manage 1990; 11: 59–73.
North American Association of Central Cancer Registries. Standards for Cancer Registries: Vol. I, Data Exchange Standards and Record Description; Vol. II, Data Standards and Data Dictionary; and Vol. III, Standards for Completeness, Quality, Analysis, and Management of Data. Cancer Surveillance and Control Program, California Department of Health Services: Sacramento, CA, 1994–1995.
Anton-Culver H, Cohen PF, Gildea ME, Ziogas A . Characteristics of BRCA1 mutations in a population-based case series of breast and ovarian cancer. Eur J Cancer 2000; 36: 1200–1208.
Ziogas A, Gildea M, Cohen P, Bringman D, Taylor TH, Seminara D et al. Cancer risk estimates for family members of a population-based family registry for breast and ovarian cancer. Cancer Epidemiol Biomarkers Prev 2000; 9: 103–111.
Li CI, Malone KE, Weiss NS, Boudreau DM, Cushing-Haugen KL, Daling JR . Relation between use of antihypertensive medications and risk of breast carcinoma among women ages 65–79 years. Cancer 2003; 98: 1504–1513.
Balkwill F, Charles KA, Mantovani A . Smoldering and polarized inflammation in the initiation and promotion of malignant disease. Cancer Cell 2005; 7: 211–217.
Li J-J, Fang C-H, Hui R-T . Is hypertension an inflammatory disease? Med Hypotheses 2005; 64: 236–240.
Cheng ZJ, Vapaatalo H, Mervaala E . Angiotensin II and vascular inflammation. Med Sci Monit 2005; 11: RA194–RA205.
Dubey RK, Oparil S, Imthurn B, Jackson EK . Sex hormones and hypertension. Cardiovascular Res 2002; 53: 688–708.
Hamet P . Cancer and hypertension: a potential for crosstalk? J Hypertens 1997; 15: 1573–1577.
Acknowledgements
This research is supported by National Cancer Institute Grant number R01 CA058860.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Largent, J., McEligot, A., Ziogas, A. et al. Hypertension, diuretics and breast cancer risk. J Hum Hypertens 20, 727–732 (2006). https://doi.org/10.1038/sj.jhh.1002075
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.jhh.1002075
Keywords
This article is cited by
-
Temporal relationships between BMI and obesity-related predictors of cardiometabolic and breast cancer risk in a longitudinal cohort
Scientific Reports (2023)
-
Cardiovascular characteristics of patients initially diagnosed breast cancer
Journal of Cardiothoracic Surgery (2021)
-
Association between blood pressure and risk of cancer development: a systematic review and meta-analysis of observational studies
Scientific Reports (2019)
-
Breast cancer and spironolactone: an observational postmarketing study
European Journal of Clinical Pharmacology (2019)
-
Hypertension and breast cancer risk: a systematic review and meta-analysis
Scientific Reports (2017)